Abstract
BackgroundThe first-line therapy for rheumatoid arthritis (RA) is weekly oral methotrexate (MTX) at low dosages (7.5–25 mg/week). However, ~40% of patients are non-adherent which may explain why some do not...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have